Which region held the largest market share in the Preclinical Respiration and Inhalation Lab Equipment Market market?

North America is the region to held the largest market share with 48% growth. Read More

Which Segment has the largest market share in the Preclinical Respiration and Inhalation Lab Equipment Market market?

Type is the segment that has the largest market share in the market. Read More

Preclinical Respiration and Inhalation Lab Equipment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Q: How much is the Preclinical Respiration and Inhalation Lab Equipment Market market?

The preclinical respiration and inhalation lab equipment market market size is estimated to grow at $$ 4.16 bn in 2023. Read More

Q: What is the growth rate of the Preclinical Respiration and Inhalation Lab Equipment Market market?

The growth rate of the preclinical respiration and inhalation lab equipment market year-over-year is 4.29%. Read More

Q: Who are the key players in the Preclinical Respiration and Inhalation Lab Equipment Market market?

4DMedical Ltd, ADInstruments Pty Ltd., Bruker Corp., CH Technologies USA Inc., Columbus Instruments LLC, CWE, emka TECHNOLOGIES, EMMS, Harvard Bioscience Inc., IN TOX PRODUCTS LLC, .... Read More

Published: Jan 2024
Pages: 158
SKU: IRTNTR44890

Enjoy complimentary customisation on priority with our Enterprise License!

Preclinical Respiration and Inhalation Lab Equipment Market 2024-2028

The preclinical respiration and inhalation lab equipment market size is forecast to increase by USD 4.16 million, at a CAGR of 4.29% between 2023 and 2028

There has been an increase in research on respiratory diseases across the globe. In addition, the market is witnessing an increase in respiratory research, which can be attributed to the growing investments in R&D activities focused on respiratory diseases. Furthermore, substantial advances have been made toward understanding the basic mechanisms of pulmonary diseases as well as optimizing their clinical management, as respiratory diseases are a major public health concern globally. Hence, such factors are positively impacting the market.

Technavio has segmented the market into Type, End-user, and Geography

The type segment is classified into respiration equipment and inhalation equipment
The end-user segment is classified into CROs and academic institutes and pharma and biotech companies
The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Preclinical Respiration and Inhalation Lab Equipment Market During the Forecast Period?

To learn more about this report, Download Report Sample

Preclinical Respiration and Inhalation Lab Equipment Market Segmentation by Type, End-user, and Geography Analysis

Type Analysis

Respiration equipment

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global preclinical respiration and inhalation lab equipment market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global preclinical respiration and inhalation lab equipment market 2018 - 2022 ($ billion)

4.2 Type Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Type - Market share 2023-2028 (%)

6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type

6.3 Respiration equipment - Market size and forecast 2023-2028
- Exhibit 34: Chart on Respiration equipment - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Respiration equipment - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Respiration equipment - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Respiration equipment - Year-over-year growth 2023-2028 (%)

6.4 Inhalation equipment - Market size and forecast 2023-2028
- Exhibit 38: Chart on Inhalation equipment - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Inhalation equipment - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Inhalation equipment - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Inhalation equipment - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ billion)
- Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 46: Chart on Comparison by End-user
- Exhibit 47: Data Table on Comparison by End-user

7.3 CROs and academic institutes - Market size and forecast 2023-2028
- Exhibit 48: Chart on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 49: Data Table on CROs and academic institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 50: Chart on CROs and academic institutes - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on CROs and academic institutes - Year-over-year growth 2023-2028 (%)

7.4 Pharma and biotech companies - Market size and forecast 2023-2028
- Exhibit 52: Chart on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Pharma and biotech companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Pharma and biotech companies - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Pharma and biotech companies - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by End-user
- Exhibit 56: Market opportunity by End-user ($ billion)
- Exhibit 57: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2023-2028 (%)
- Exhibit 60: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 France - Market size and forecast 2023-2028
- Exhibit 87: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on France - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ billion)
- Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 4DMedical Ltd
- Exhibit 107: 4DMedical Ltd - Overview
- Exhibit 108: 4DMedical Ltd - Product / Service
- Exhibit 109: 4DMedical Ltd - Key offerings

12.4 ADInstruments Pty Ltd.
- Exhibit 110: ADInstruments Pty Ltd. - Overview
- Exhibit 111: ADInstruments Pty Ltd. - Product / Service
- Exhibit 112: ADInstruments Pty Ltd. - Key offerings

12.5 Bruker Corp.
- Exhibit 113: Bruker Corp. - Overview
- Exhibit 114: Bruker Corp. - Business segments
- Exhibit 115: Bruker Corp. - Key offerings
- Exhibit 116: Bruker Corp. - Segment focus

12.6 CH Technologies USA Inc.
- Exhibit 117: CH Technologies USA Inc. - Overview
- Exhibit 118: CH Technologies USA Inc. - Product / Service
- Exhibit 119: CH Technologies USA Inc. - Key offerings

12.7 Columbus Instruments LLC
- Exhibit 120: Columbus Instruments LLC - Overview
- Exhibit 121: Columbus Instruments LLC - Product / Service
- Exhibit 122: Columbus Instruments LLC - Key offerings

12.8 CWE
- Exhibit 123: CWE - Overview
- Exhibit 124: CWE - Product / Service
- Exhibit 125: CWE - Key offerings

12.9 emka TECHNOLOGIES
- Exhibit 126: emka TECHNOLOGIES - Overview
- Exhibit 127: emka TECHNOLOGIES - Product / Service
- Exhibit 128: emka TECHNOLOGIES - Key offerings

12.10 EMMS
- Exhibit 129: EMMS - Overview
- Exhibit 130: EMMS - Product / Service
- Exhibit 131: EMMS - Key offerings

12.11 Harvard Bioscience Inc.
- Exhibit 132: Harvard Bioscience Inc. - Overview
- Exhibit 133: Harvard Bioscience Inc. - Product / Service
- Exhibit 134: Harvard Bioscience Inc. - Key offerings

12.12 IN TOX PRODUCTS LLC
- Exhibit 135: IN TOX PRODUCTS LLC - Overview
- Exhibit 136: IN TOX PRODUCTS LLC - Product / Service
- Exhibit 137: IN TOX PRODUCTS LLC - Key offerings

12.13 Kent Scientific Corp.
- Exhibit 138: Kent Scientific Corp. - Overview
- Exhibit 139: Kent Scientific Corp. - Key offerings

12.14 Lab Products Inc.
- Exhibit 140: Lab Products Inc. - Overview
- Exhibit 141: Lab Products Inc. - Product / Service
- Exhibit 142: Lab Products Inc. - Key offerings

12.15 NuAire Inc.
- Exhibit 143: NuAire Inc. - Overview
- Exhibit 144: NuAire Inc. - Product / Service
- Exhibit 145: NuAire Inc. - Key offerings

12.16 RWD Life Science Co. Ltd.
- Exhibit 146: RWD Life Science Co. Ltd. - Overview
- Exhibit 147: RWD Life Science Co. Ltd. - Product / Service
- Exhibit 148: RWD Life Science Co. Ltd. - Key offerings

12.17 TSE Systems GmbH
- Exhibit 149: TSE Systems GmbH - Overview
- Exhibit 150: TSE Systems GmbH - Product / Service
- Exhibit 151: TSE Systems GmbH - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 152: Inclusions checklist
- Exhibit 153: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 154: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 155: Research methodology
- Exhibit 156: Validation techniques employed for market sizing
- Exhibit 157: Information sources